Hill MD - Search Results

1

The albumin in acute stroke trial (ALIAS); design and methodology.

Hill MD, Moy CS, Palesch YY, Martin R, Dillon CR, Waldman BD, Patterson L, Mendez IM, Ryckborst KJ, Tamariz D, Ginsberg MD; ALIAS Investigators. Hill MD, et al. Int J Stroke. 2007 Aug;2(3):214-9. doi: 10.1111/j.1747-4949.2007.00143.x. Int J Stroke. 2007. PMID: 18705947 Clinical Trial.

2

Acute intravenous--intra-arterial revascularization therapy for severe ischemic stroke.

Hill MD, Barber PA, Demchuk AM, Newcommon NJ, Cole-Haskayne A, Ryckborst K, Sopher L, Button A, Hu W, Hudon ME, Morrish W, Frayne R, Sevick RJ, Buchan AM. Hill MD, et al. Stroke. 2002 Jan;33(1):279-82. doi: 10.1161/hs0102.101900. Stroke. 2002. PMID: 11779923 Clinical Trial.

3

Weather, Chinook, and stroke occurrence.

Field TS, Hill MD. Field TS, et al. Among authors: hill md. Stroke. 2002 Jul;33(7):1751-7. Stroke. 2002. PMID: 12105347

4

Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS.

Hill MD, Rowley HA, Adler F, Eliasziw M, Furlan A, Higashida RT, Wechsler LR, Roberts HC, Dillon WP, Fischbein NJ, Firszt CM, Schulz GA, Buchan AM; PROACT-II Investigators. Hill MD, et al. Stroke. 2003 Aug;34(8):1925-31. doi: 10.1161/01.STR.0000082483.37127.D0. Epub 2003 Jul 3. Stroke. 2003. PMID: 12843342 Clinical Trial.

5

Mild neurological symptoms despite middle cerebral artery occlusion.

Coutts SB, Barber PA, Demchuk AM, Hill MD, Pexman JH, Hudon ME, Buchan AM. Coutts SB, et al. Among authors: hill md. Stroke. 2004 Feb;35(2):469-71. doi: 10.1161/01.STR.0000110985.01773.7F. Epub 2004 Jan 15. Stroke. 2004. PMID: 14726548

6

Is intravenous recombinant tissue plasminogen activator (rt-PA) safe for use in patients over 80 years old with acute ischaemic stroke? - The Calgary experience.

Simon JE, Sandler DL, Pexman JH, Hill MD, Buchan AM; Calgary Stroke Programme. Simon JE, et al. Among authors: hill md. Age Ageing. 2004 Mar;33(2):143-9. doi: 10.1093/ageing/afh031. Age Ageing. 2004. PMID: 14960429

7

Intra-arterial thrombolysis in acute ischemic stroke: a review of pharmacologic approaches.

Pettersen JA, Hudon ME, Hill MD. Pettersen JA, et al. Among authors: hill md. Expert Rev Cardiovasc Ther. 2004 Mar;2(2):285-99. doi: 10.1586/14779072.2.2.285. Expert Rev Cardiovasc Ther. 2004. PMID: 15151476 Review.

8

Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials.

Kent DM, Price LL, Ringleb P, Hill MD, Selker HP. Kent DM, et al. Among authors: hill md. Stroke. 2005 Jan;36(1):62-5. doi: 10.1161/01.STR.0000150515.15576.29. Epub 2004 Nov 29. Stroke. 2005. PMID: 15569865

9

Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study.

Hill MD, Buchan AM; Canadian Alteplase for Stroke Effectiveness Study (CASES) Investigators. Hill MD, et al. CMAJ. 2005 May 10;172(10):1307-12. doi: 10.1503/cmaj.1041561. CMAJ. 2005. PMID: 15883405 Free PMC article.

10

Coding of stroke and stroke risk factors using international classification of diseases, revisions 9 and 10.

Kokotailo RA, Hill MD. Kokotailo RA, et al. Among authors: hill md. Stroke. 2005 Aug;36(8):1776-81. doi: 10.1161/01.STR.0000174293.17959.a1. Epub 2005 Jul 14. Stroke. 2005. PMID: 16020772

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

995 results

Search Page

Filters